Benjamin N. J. Thomson

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Peter Gibbs · 10 shared papers, 2019–2026 · strength 1.66
   • Paper Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pa… DOI 10.1111/ans.70705↗
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
   • Paper Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic canc… DOI 10.1186/s12889-025-23925-4↗
2. Belinda Lee · 8 shared papers, 2019–2025 · strength 1.27
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
   • Paper Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic canc… DOI 10.1186/s12889-025-23925-4↗
   • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
3. Mehrdad Nikfarjam · 7 shared papers, 2019–2026 · strength 1.10
   • Paper Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pa… DOI 10.1111/ans.70705↗
   • Paper Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic canc… DOI 10.1186/s12889-025-23925-4↗
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
4. Benjamin P. T. Loveday · 6 shared papers, 2019–2026 · strength 1.09
   • Paper Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pa… DOI 10.1111/ans.70705↗
   • Paper Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic canc… DOI 10.1186/s12889-025-23925-4↗
   • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
5. Sam Banks · 3 shared papers, 2024–2026 · strength 0.60
   • Paper Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pa… DOI 10.1111/ans.70705↗
   • Paper Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic canc… DOI 10.1186/s12889-025-23925-4↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
6. Hyun Soo Ko · 3 shared papers, 2022–2025 · strength 0.55
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
   • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
7. Adnan M. Nagrial · 4 shared papers, 2019–2024 · strength 0.51
   • Paper Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospit… DOI 10.1111/ajco.13721↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
   • Paper Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australa… DOI 10.1111/ajco.13807↗
8. Shehara Ramyalini Mendis · 3 shared papers, 2022–2025 · strength 0.51
   • Paper Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic canc… DOI 10.1186/s12889-025-23925-4↗
   • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
   • Paper Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospit… DOI 10.1111/ajco.13721↗
9. Matthew Burge · 4 shared papers, 2019–2024 · strength 0.49
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
   • Paper Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australa… DOI 10.1111/ajco.13807↗
   • Paper Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cance… DOI 10.1016/j.ejca.2022.06.042↗
10. Yat Hang To · 3 shared papers, 2022–2024 · strength 0.47
    • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
    • Paper Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospit… DOI 10.1111/ajco.13721↗
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
11. Adrian M. Fox · 3 shared papers, 2023–2024 · strength 0.45
    • Paper Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data. DOI 10.1038/s41416-024-02619-5↗
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
    • Paper Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australa… DOI 10.1111/ajco.13807↗
12. Silja Schrader · 1 shared paper, 2026 · strength 0.26
    • Paper Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pa… DOI 10.1111/ans.70705↗
13. Jon D. Emery · 1 shared paper, 2026 · strength 0.26
    • Paper Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pa… DOI 10.1111/ans.70705↗
14. Sebastian Nowak · 1 shared paper, 2025 · strength 0.24
    • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
15. Julian Alexander Luetkens · 1 shared paper, 2025 · strength 0.24
    • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
16. Maike Theis · 1 shared paper, 2025 · strength 0.24
    • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
17. Niall Christopher Tebbutt · 2 shared papers, 2019–2023 · strength 0.20
    • Paper Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australa… DOI 10.1111/ajco.13807↗
    • Paper Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic… DOI 10.1093/annonc/mdz200↗
18. Marion Harris · 2 shared papers, 2019–2023 · strength 0.20
    • Paper Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australa… DOI 10.1111/ajco.13807↗
    • Paper Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic… DOI 10.1093/annonc/mdz200↗
19. Prasad D. Cooray · 2 shared papers, 2019–2023 · strength 0.20
    • Paper Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australa… DOI 10.1111/ajco.13807↗
    • Paper Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic… DOI 10.1093/annonc/mdz200↗
20. Emma Sanderson · 1 shared paper, 2025 · strength 0.19
    • Paper Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic canc… DOI 10.1186/s12889-025-23925-4↗
21. Margaret Lee · 1 shared paper, 2025 · strength 0.19
    • Paper Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic canc… DOI 10.1186/s12889-025-23925-4↗
22. Alexander Grogan · 1 shared paper, 2022 · strength 0.16
    • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
23. Hui‐Li Wong · 1 shared paper, 2022 · strength 0.16
    • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
24. Imogen Walpole · 1 shared paper, 2023 · strength 0.14
    • Paper Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australa… DOI 10.1111/ajco.13807↗
25. Jordan Santucci · 1 shared paper, 2022 · strength 0.13
    • Paper Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cance… DOI 10.1016/j.ejca.2022.06.042↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.